Supramolecular Polymer Putty for Spinal Fusion Bone Regeneration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current spinal fusion methods face challenges with iliac crest autograft bone's limited availability and high-cost alternatives like BMP-2, which have safety concerns and restricted use, necessitating a more effective and safer synthetic option for bone/tissue repair and regeneration.

Innovation Solution

Compositions comprising peptide amphiphile nanofibers, soft covalent polymers, and ceramic materials, such as PEG and hydroxyapatite, are developed to create a composite putty-like material that promotes bone/tissue repair and regeneration, potentially incorporating bioactive factors like BMP-2 for enhanced osteogenesis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If BMP-2 is used for spinal fusion, then fusion results are consistent and reliable, but safety concerns arise due to supraphysiological doses and manufacturing costs become prohibitive

Engineering Contradiction:
Improvefusion resultsVSAvoidsafety concerns
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent introduces an intermediary system consisting of peptide amphiphile nanofibers that bind and deliver BMP-2 in a controlled manner. The nanofiber structure acts as a mediator between the BMP-2 protein and the bone tissue, enabling physiological dosing by improving delivery efficiency and reducing the need for supraphysiological amounts of BMP-2.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent changes the delivery parameters of BMP-2 by incorporating it into a composite putty material with specific mechanical properties (storage modulus 100-5000 Pa). This allows control over the release kinetics and local concentration of BMP-2, enabling physiological dosing while maintaining effective fusion outcomes.

Inventive Principle:
Principle #35Parameter changes

2Reliability

If BMP-2 is used for spinal fusion, then fusion outcomes are consistent, but manufacturing costs become prohibitive for adoption

Engineering Contradiction:
Improvefusion outcomesVSAvoidmanufacturing costs
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent employs a disposable composite putty material that combines inexpensive ceramic particles (hydroxyapatite, tricalcium phosphate) with peptide amphiphile nanofibers. This approach replaces expensive recombinant BMP-2 products with a cost-effective composite material that can be manufactured at scale and disposed of after single use, eliminating the need for expensive protein manufacturing and purification processes.

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Ease of manufacture

If iliac crest autograft bone is used for spinal fusion, then cost is low and fusion results are reliable, but harvest site morbidity and limited volume occur

Engineering Contradiction:
ImprovecostVSAvoidharvest site morbidity
Core Design Contradiction:
Ease of manufactureVSObject-affected harmful factors

Solution Approach 1:

The patent extracts the essential osteogenic function from the iliac crest autograft (which provides both structural support and biological activity) and separates it into two components: a synthetic structural scaffold (composite putty with ceramic particles and polymer matrix) and a biological activator (BMP-2 delivered via peptide nanofibers). This eliminates the need for harvest site surgery while maintaining the dual functions of structure and biology.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent creates a composite material combining synthetic polymers (for structural support and mechanical properties), ceramic particles (for osteoconductivity and bone integration), and peptide amphiphile nanofibers (for targeted BMP-2 delivery). This composite approach replicates the multifunctionality of autograft bone without requiring harvest site surgery.

Inventive Principle:
Principle #40Composite materials

4Adaptability or versatility

If a synthetic bone graft material is used, then availability is improved, but biological activity and osteogenesis capability are reduced

Engineering Contradiction:
ImproveavailabilityVSAvoidosteogenesis capability
Core Design Contradiction:
Adaptability or versatilityVSReliability

Solution Approach 1:

The patent introduces peptide amphiphile nanofibers as an intermediary that bridges the gap between synthetic materials and biological activity. These nanofibers provide a biomimetic interface that specifically binds BMP-2 and delivers it to bone progenitor cells, conferring osteogenic capability to the synthetic composite material while maintaining broad availability and ease of manufacture.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The composite material effectively supports bone/tissue repair and regeneration, offering a safer and more reliable alternative to existing methods by enhancing spinal fusion rates and reducing the need for high-dose BMP-2, while being cost-effective.

Implementation Method 1

peptide amphiphile nanofibers comprise a supramolecular assembly of peptide amphiphiles

Methodology Applied
Scientific EffectSelf-assembly: Self-Assembly

Implementation Method 2

peptide amphiphiles comprising: (i) a hydrophobic non-peptidic segment; (ii) a structural peptide segment; and (iii) a charged segment

Methodology Applied
Scientific EffectHydrophobic interaction: Hydrophobe

Implementation Method 3

the polymer component comprises polyethylene glycol (PEG)

Methodology Applied
Scientific EffectHydrophilic interaction: Hydrophile

Implementation Method 4

the ceramic component comprises hydroxyapatite (HA), tricalcium phosphate (TCP), bioglass, calcium sulfate

Methodology Applied
Scientific EffectOsteoconduction:

Implementation Method 5

the bioactive peptide segment mimics the biological function of or is capable of binding to a bioactive factor and/or cellular component

Methodology Applied
Scientific EffectMolecular binding: Adsorption

Data Source

PatentUS20250381321A1Supramolecular polymer putty for bone/tissue regeneration
Publication Date: 2025.12.18 AMPHIX BIO INC
  • US20250381321A1 patent drawing
  • US20250381321A1 patent drawing
  • US20250381321A1 patent drawing

AI summary

Spinal fusion is a surgical procedure to treat debilitating back and neck pain where two adjacent spinal vertebrae are fused by inducing bone growth between them. While iliac crest autograft bone has been the gold standard for spinal fusions due to its low cost and reliable fusion results, harvest site morbidity and limited volume have led to a search for alternatives. Provided herein are compositions comprising peptide amphiphiles, soft covalent polymers, and ceramic materials. Composite putty-like materials are provided for medical uses, in particular for the repair of bone/tissue injuries/defects and the regeneration of bone or other tissue.